NDV-D90 suppresses growth of gastric cancer and cancer-related vascularization

This publication has 25 references indexed in Scilit:

• Newcastle disease virus employs macropinocytosis and Rab5a-dependent intracellular trafficking to infect DF-1 cells
  Oncotarget, 2016
• Free intraperitoneal tumor cells and outcome in gastric cancer patients: a systematic review and meta-analysis
  Oncotarget, 2015
• Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy
  Oncotarget, 2015
• Use of Reverse Genetics to Enhance the Oncolytic Properties of Newcastle Disease Virus
  Cancer Research, 2007
• Phase 1 Clinical Experience Using Intravenous Administration of PV701, an Oncolytic Newcastle Disease Virus
  Current Cancer Drug Targets, 2007
• A Phase 1 Clinical Study of Intravenous Administration of PV701, an Oncolytic Virus, Using Two-Step Desensitization
  Clinical Cancer Research, 2006
• Phase I/II Trial of Intravenous NDV-HUJ Oncolytic Virus in Recurrent Glioblastoma Multiforme
  Molecular Therapy, 2006
• A Phase Ib Clinical Trial of PV701, a Milk-Derived Protein Extract, for the Prevention and Treatment of Oral Mucositis in Patients Undergoing High-Dose BEAM Chemotherapy
  Transplantation and Cellular Therapy, 2005
• MTH-68/H Oncolytic Viral Treatment in Human High-Grade Gliomas
  Journal of Neuro-Oncology, 2004
• Enhanced Replication of Newcastle Disease Virus in Cell Culture Co-infected with Certain Other Viruses
  Japanese Journal of Microbiology, 1968